as 07-26-2024 4:00pm EST
PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Products and Services segments. It also provides third-party products to retailers which for a long time are available for veterinary clinics only. Its proprietary brands include PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, TruProfen, Betsy Farms, PetAction, Minties, Vera and Delightibles. The company generates maximum revenue from Products segment.
Founded: | 2010 | Country: | United States |
Employees: | N/A | City: | EAGLE |
Market Cap: | 641.2M | IPO Year: | 2017 |
Target Price: | $29.00 | AVG Volume (30 days): | 344.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.22 | EPS Growth: | N/A |
52 Week Low/High: | $15.09 - $22.98 | Next Earning Date: | 08-07-2024 |
Revenue: | $1,119,935,000 | Revenue Growth: | 19.61% |
Revenue Growth (this year): | 7.35% | Revenue Growth (next year): | 5.49% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Huff Scott | PETQ | Director | Jun 12 '24 | Sell | $22.19 | 12,117 | $268,876.23 | 0 | SEC Form 4 |
PETQ Breaking Stock News: Dive into PETQ Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
Zacks
a month ago
GlobeNewswire
2 months ago
PR Newswire
2 months ago
Business Wire
2 months ago
Business Wire
2 months ago
Reuters
2 months ago
Investor's Business Daily
2 months ago
The information presented on this page, "PETQ PetIQ Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.